ADHD drugs and cardiovascular risk [19]

Thomas Anders; Steven Sharfstein

doi:10.1056/NEJMc061187

ADHD drugs and cardiovascular risk [19]

Thomas Anders, Steven Sharfstein

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2296
Number of pages	1
Journal	New England Journal of Medicine
Volume	354
Issue number	21
DOIs	https://doi.org/10.1056/NEJMc061187
State	Published - May 25 2006
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc061187

Cite this

@article{c1e200d293154e7c98c9d848fe9930a4,

title = "ADHD drugs and cardiovascular risk [19]",

author = "Thomas Anders and Steven Sharfstein",

year = "2006",

month = may,

day = "25",

doi = "10.1056/NEJMc061187",

language = "English (US)",

volume = "354",

pages = "2296",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "21",

}

TY - JOUR

T1 - ADHD drugs and cardiovascular risk [19]

AU - Anders, Thomas

AU - Sharfstein, Steven

PY - 2006/5/25

Y1 - 2006/5/25

UR - http://www.scopus.com/inward/record.url?scp=33646860996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646860996&partnerID=8YFLogxK

U2 - 10.1056/NEJMc061187

DO - 10.1056/NEJMc061187

M3 - Letter

C2 - 16723628

AN - SCOPUS:33646860996

SN - 0028-4793

VL - 354

SP - 2296

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 21

ER -

ADHD drugs and cardiovascular risk [19]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this